This free script provided by
JavaScript Kit


Catalog #:


Shipping advice:

Suitable for Standard Delivery only (2-3 days). International shipping rate please contact us for details

IN0063-100mg USD100.0

References for bumetanide:

1. Pollo, F., Sequinel, R., Rufino, J. L., Los Weinert, P., Pezza, H. R., and Pezza, L. An environmentally friendly reflectometric method for bumetanide determination in pharmaceuticals. Anal Sci, 25: 897-901, 2009.

2. Vanhatalo, S., Hellstrom-Westas, L., and De Vries, L. S. Bumetanide for neonatal seizures: Based on evidence or enthusiasm? Epilepsia, 50: 1292-1293, 2009.

3. Kahle, K. T., Barnett, S. M., Sassower, K. C., and Staley, K. J. Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol, 24: 572-576, 2009.

4. Migliati, E., Meurice, N., DuBois, P., Fang, J. S., Somasekharan, S., Beckett, E., Flynn, G., and Yool, A. J. Inhibition of aquaporin-1 and aquaporin-4 water permeability by a derivative of the loop diuretic bumetanide acting at an internal pore-occluding binding site. Mol Pharmacol, 76: 105-112, 2009.

5. Nardou, R., Ben-Ari, Y., and Khalilov, I. Bumetanide, an NKCC1 antagonist, does not prevent formation of epileptogenic focus but blocks epileptic focus seizures in immature rat hippocampus. J Neurophysiol, 101: 2878-2888, 2009.

6. Mazarati, A., Shin, D., and Sankar, R. Bumetanide inhibits rapid kindling in neonatal rats. Epilepsia, 50: 2117-2122, 2009.

Certificate of Analysis/MSDS is available upon request with lot number

Home | Contact | Support | Privacy Policy, Terms Warranty | Apycom jQuery Menus